Further areas of study should include randomized clinical trials that enroll a larger cohort of patients with nAMD complicated by a large SRH with subfoveal hemorrhage and compare faricimab monotherapy to other anti-VEGF therapies. Here, VEGFA is linked to hemorrhage.